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INTRODuCTION
Glial-derived neurotrophic factor (GDnF) belongs to the 
GDnF-similar ligand (GFL) family, which includes neur-
turin (nrtn), persipin (PSPn), and artemin (Artn).  All 
of these are necessary for the survival of the dopaminergic 
neurons of the mesencephalon, as well as for peripheral sen-
sory and sympathetic neurons (with the exception of PSPn) 
[12, 14]. In addition, beyond the nervous system, GDnF ful-
fills the following important functions: it regulates the dif-
ferentiation of spermatogonia and is needed for the embry-
onic development of kidneys [14]. 
All representatives of the GFL family influence the cells 
through bonding with the heteroreceptor complex, which 
contains the ret receptor and GFrα co-receptor [14]. the 
specificity of the ret receptor activation, in relation to dif-
ferent factors of the GFL family, depends on the GFrα type 
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contained in the cells. GDnF, nrtn, Artn, and PSPn have 
strong affinities to GFrα1, GFrα2, GFrα3, and GFrα4 co-
receptors, respectively. GFL binding with the “alien” GFrα 
is possible, but it happens with less efficiency. It has been 
shown that GDnF increases the survival rate of the dop-
aminergic neurons of rats’ embryonic mesencephalon in a 
specific way, making the dopamine metabolism stronger; it 
also increases the differentiation level of tyrosine hydroxi-
lase-positive cells (tH+), raising the axons’ growth and in-
creasing the dimensions of the cell’s body.  Analogous effects 
have also been observed in rats’ mesencephalon dopaminer-
gic neurons [12]. Similar results have been obtained on fruit-
fly transgenic lines. It appeared that a distinct synthesis of 
tyrosine hydroxilase has been found in the fruit fly’s lines 
bearing the GDnF gene and in differentiating nerve cells, 
and the fruit fly’s cells bearing the GDnF gene were active-
ly producing acetylcholinesterase [2, 3] 
embryonic Scs are able to self-renew and differentiate to 
the derivatives of all three primary embryonic leaves both 
in vitro and in vivo. Most importantly, in the course of the 
embryonic Scs, the differentiation of the order of expres-
sion and the tissue-specific genes correspond to the order 
of these processes during the development of the organism 
in vivo [7]. 
the ability of the Scs to differentiate in definite direc-
tions in vitro makes it possible to study the cell and the mo-
lecular mechanisms of early development on this type of 
model, as well as to receive different types of donor cells for 
transplantation. Prioritized embryonic Sc differentiation in 
a definite direction is achieved only with specific cultivat-
ing conditions  [9] after exogenous growth factors are ap-
plied and after differentiation  [7] by way of their genetic 
modification [1, 10, 11, 13]. the first research works on em-
bryonic Sc-directed differentiation were conducted mostly 
on mouse embryonic Scs, whose differentiation with the 
help of the above-mentioned methods could be directed to 
the hemopoetic cells [16], cardiomyocytes [11], insulin-se-
creting cells [15], and neurons and glia cells [4, 6]. the use 
of the combined methods of genetic manipulation with 
mouse embryonic-Sc cultivaton on the feeder layer of stro-
mal cells has shown a significant increase in the number of 
dopaminergic neurons (approximately twice as many) in 
the pilot test as in the control one. the results of tests on 
the transplantation of such cells have shown the efficient 
integration of the tH+ cells into the mouse’s striatum [10]. 
the induction of dopaminergic differentiation was shown 
on human embryonic Scs with condition of their cultivation 
on the stromal P06 cells [18]. Preserving the vitality of the 
dopaminergic neurons during their transplantation remains 
essential. Buytaert–Hoefen et al. [5] showed that, in order to 
improve the vitality of the dopaminergic neurons, the pres-
ence of a factor such as the GDnF factor or astrocytes from 
the striatum is necessary. Japanese researchers [17], using 
the primate embryonic-Sc cocultivating technique on Ser-
toli cells secreting GDnF, found not only an increase in the 
number of induced dopaminergic neurons over the control-
test number, but they also successfully transplanted these 
cells to the mouse’s striatum, which has a pathology similar 
to Parkinson’s disease in humans.  embryonic Scs obtained 
as a result of definite experimental manipulations, including 
genetic ones, and possessing a specific type of directed dif-
ferentiation may be used in the future in cellular therapy of 
several critical human illnesses.
In connection with this, examining embryonic Scs with 
increased GDnF expression genes is essential. In order to 
achieve that, in this article embryonic-Sc polyclonal cul-
tures of mice were obtained and transfected with the hu-
man GDnF gene fused with the gene that codes the “green” 
fluorescent protein (GFP); they were then described.
ExPLORATORy PROCEDuRE
CuLTIVATING MOuSE EMBRyONIC SCS cultivating the embry-
onic Scs was done at 370С and 5% СО2 in α-MeM (Sigma, 
united States) medium containing 15% cow fetal serum 
(cFS) (Gibco, united States), 0.1 mM 2- mercaptoethanol, 2 
mM L-glutamine,  nonessential amino acids (Gibco, united 
States), nucleosides, vitamins, and gentamicin antibiotic (20 
microgram/ml). As a nourishing (feeder) layer for the em-
bryonic Scs, primary fibroblasts received from embryonic 
mice in the 11th–12th day of development were used, the 
proliferation of which was blocked by mitomycin c (3 mi-
crogram/ml). the medium for growing the primary fibro-
blast culture was DMeM (Sigma, united States) containing 
10% cFS, 2 mM L-glutamine, and gentamicin antibiotic (20 
microgram/ml). When cultivating embryonic Scs without 
the feeder layer, leukemia inhibiting factor (LIF) (Sigma, 
united States) was added in a final concentration of 10 ng/
ml, which blocked the spontaneous differentiation of these 
cells. the cells were reseeded and medium-changed every 
3 days.
ESTIMATING THE ExPRESSION LEVEL OF THE RET AND GFRα1 RECEP-
TORS wITH THE HELP OF POLyMERASE CHAIN REACTION COuPLED 
wITH THE REVERSED TRANSCRIPTION (RT-PCR) the total DnA 
from the non-differentiated embryonic Scs, which were cul-
tivated without the feeder layer in the presence of LIF, were 
extracted following the manufacturer’s recommendations 
by the method of phenol-chloroform extraction with the 
use of the YellowSolve (clonogen, united States) kit. the 
reversed transcription procedure was held with the use of 
the Silex company (russia) kit according to the protocol and 
recommendations of the manufacturer. kDnA synthesis was 
done on  2 micrograms of the total rnA for 1 h at 370 С in 25 
microliters of reaction mixture containing 0.05 micrograms 
of accidental hexaprimers and 100 units of  MMLV (molonеy 
murine leukemia virus) reverse transcriptase. After the ces-
sation of the reaction (10 min incubation at 700С), the sam-
ples of kDnA were kept at –200 С.
Polymerase chain reaction (Pcr) was conducted in a 
25 microliter reaction mixture composed of а taq-buffer, 
1.5 mM of the dntP mixture, 1.25 units of “colored” taq 
polymerase (Sintol russia), 0.5 micro grams of kDnA sam-
ple, and 10 Pmol of each primer. 
the primers’ sequences used in the tests are given be-
low. [8] 
For the ret gene: 5’-cctccGtGAcAGccGcAAGA-3’ 
(forward), 5’-GGGAAtccGGcccttGcttt-3’ (reverse); 
size of the product 297 bps
For the GFrα1 gene: 5’-tcAttGGcAGAAAcAtcG-reSeArcH ArtIcLeS
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tAG-3’ (forward), 5’-GctcAGcttGctttAcAGtcc-
3’(reverse); size of the product 285 bps 
conditions of the Pcr were the same for both fragments: 
5 min at 520c, 5 min at 950c, then 35 cycles, including at 950c 
for 30 sec; at 680c for 30 sec; at 720c for 30 sec, and at 720c 
for 10 min. the products of the Pcr were separated by elec-
trophoresis in 1.5% agarose gel with visualization with the 
help of lower bromide etidium. 
NORTHERN HyBRIDIzATION  mrnA was extracted from the em-
bryonic Scs using trI reAGent (Sigma, united States) 
according to the protocol of the manufacturer and sepa-
rated by electrophoresis in 1.5% agarose gel. then, mrnA 
was transferred on the nylon membrane.  the probe for 
GDnF gene was marked by the α-32P АТР with the help of 
the random Prime Labeling Kit (Promega, united States) in 
accordance to the instructions of the manufacturer. Prehy-
bridization was carried out in the hybridization buffer (Х5 
SSPe, 0.1% SDS, Х5 Denhardt solution) for 1 h at 65°С. the 
labeled probe was denaturized for 5 min at 100°С and added 
to the hybridization buffer.
Hybridization was conducted for 16–20 hours at 65°С 
on the water bath. then, the filter was washed 3 times (for 
15 min each time) in the Х0.l SSc, 0.1% SDS solution and 
wrapped in a waterproof plastic film and put into the pho-
to film holder with the photo film. then it was exposed at 
–70°С for 1 to 5 days.     
RECOMBINANT PLASMIDS  Following genetic engineering, con-
structions were used for the cells transfection.  pEGFP-N1 
control plasmid (Fig.1A) contained the GFP gene under the 
(cMV) cytomegalovirus promoter and a gene resistant to ne-
omycin neo antibiotic. the size of the plasmid is 4.7 thousand 
bts.  LP14g plasmid (Fig.1B) carrying the human GDnF gene 
fused with the GFP gene was constructed on the pEGFP-N1 
basis.  the plasmid's size is 5.3 thousand bps, and the plas-
mid's structures are shown in Fig. 1. 
EMBRyONIC SCS TRANSFECTION AND SELECTION Insertion of the 
plasmid DnA into embryonic Scs was carried out with the 
help of electroporation using a SuM4 device (V.A.engelgardt 
Molecular Biology Institute,  russian Academy of Sciences) 
at the following characteristics selected through experi-
ments: impulse duration was 1.5 microseconds, and 400 V 
voltage. For the transfection of one million cells, 6–8 mi-
crograms of plasmid DnA were used. trnsfected cells were 
seeded, 300,000 in each Petri cup (35 mm diameter, gelatin 
covered (0.01%) in 2 ml of the standard for the embryonic-
Sc medium with the addition of LIF (10ng/ml)). Selection 
began on the second day after seeding by adding the antibi-
otics G418 (200 microgram/ml) to the medium. the selective 
medium was changed every 3–4 days. Polyclonal cultures 
of each transfection version were gathered on the 10th day 
from the cups in the form of a summary pool of G418-resist-
ent clones. transfected cells were analyzed visually under 
an Axioscope (Karl Zeiss, Germany) microscope. the aver-
age transfection efficiency was about 10-4 .
DETERMINING THE PROLIFERATIVE ACTIVITy OF THE EMBRyONIC 
SCS An estimation of the proliferative activity of the control 
and transfected lines was conducted on the third day after 
seeding by directly calculating the cells under an Olym-
pus СКХ41 (Olympus, Japan) microscope in the Goryayev 
chamber.
EMBROID BODy PRODuCTION For the induction of differentia-
tion with the production of embroid bodies (eB), the em-
bryonic Scs were isolated from the fibroblasts of the feeder 
layer. In order to do this, the cells were processed in tripsin, 
centrifugated, and then the obtained suspension was incu-
bated in Petri cups (d = 60mm) (nunc, Denmark) for 15–30 
min.  During that time, most of the mass of fibroblasts sticks 
to the cup’s bottom while the embryonic Scs remain in the 
suspension. to form eB, the embryonic Scs suspension was 
transferred either to the Petri cup (d = 60mm) (nunc, Den-
mark) in an amount of 500,000 or to the 96-well immunology 
plate (1,000 cells on each well) and then placed into a СО2-
incubator (5% СО2). calculating the number of the produced 
eB was done on the 3th–4th cultivation day.  
to form single eBs, the “hanging drop” method was ap-
plied [7]. embryonic Scs cultivated on the gelatin substrate 
in the medium with LIF (Sigma, united States) added were 
Fig. 1. peGFp-N1 
and lp14g plasmid 
construction sche‑
matics for embry‑
onic SCs transfection.     
Kan/Neo is a gene 
providing resist‑
ance to antibiotics, 
EGFP is the “green 
protein” gene, MCS 
is the sequence 
containing restriction 
sites, and hGDNF 
is the human GDNF 
gene insertion.
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used for this. cells were processed with tripsin, and a sus-
pension with 25,000 cells/ml was prepared. Fifty drops of 
20 microliters containing 500 cells each were placed on the 
lid of a Petri cup (nunc, Denmark) 60 mm in diameter. In 
order to get a humid atmosphere, Hanks solutions (2 ml) 
were added to the cups and then they were placed into the 
СО2-incubator (5% СО2). On the third cultivating day, the 
produced eBs were transferred to the 4-well substrates (the 
diameter of one well is 15 mm) precoated with gelatin for 
further differentiation.
AN IMMuNOCyTOCHEMICAL ANALySIS OF THE PRESENCE OF THE 
GDNF HuMAN GENE PROTEIN PRODuCT IN THE TRANSFECTED LINES 
OF EMBRyONIC SCS three-day-old eBs were cultivated in the 
Fig. 2. Receptors GFRα1 and RET expression analysis in the R1 line mouse embryonic SCs.  
(A) is the GFRα1 receptor’s expression. M is the fragments lengths marker, 1 is the mouse’s hippocampus (positive control), 2 is the mouse’s hip‑
pocampus control on the genomic DNA impurity, 3 is the line R1 embryonic SCs, and 4 is the line R1 embryonic SCs control on the genomic DNA impu‑
rity. The length of the product is 285 bps
(B) is the RET receptor expression, 5 is the hippocampus (positive control), 6 is the mouse’s hippocampus control on the genomic DNA impurity, 7 is the 
R1 line embryonic SC R1‑ line, 8 is the R1 line embryonic SC control on the genomic DNA impurity, and 9 is the water. The length of the product is 297 bps
Fig. 3. es‑GDNF line 
cells colonies in (A) 
the light microscope 
and (B) fluorescent 
microscope (x 100).
4-well tray with a 15-mm well diameter (nunc, Denmark) 
(3–4 bodies per one well) processed with 0.01% gelatin in 
700 microliters of embryonic Scs cultivating  medium not 
containing LIF. On the 7th cultivation day, differentiated 
cells were fixed by 4% paraformaldehyde in PBS for 30 min 
at room temperature. After being washed three times, PBS 
cells were pre-incubated in the PBS solution containing 0.1% 
triton X-100 and 5% FBS for 15 min at room temperature.   
chicken polyclonal antibodies were used as primary anti-
bodies against human GDnF (Promega, united States) in a 
1 : 30 dilution in the PBS-0.1% triton-5% FBS solution. Incu-
bation was conducted for one night at +40С. After washing 
PBS three times, secondary biotynilated rabbit antibodies 
were brought on against chicken immunoglobulins (Imtek, 
A B
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pens in the embryonic Scs.  to detect the protein product 
synthesis in this gene, the differentiated cells of the es-GD-
nF and es-GFP were colorated with the help of polyclonal to 
human GDnF antibodies. the results of the experiments are 
presented in Figs. 5 A and 5B. the slight pink coloring (Fig. 
5A) is due to the fact that embryonic Scs seemingly synthe-
Fig. 4. GDNF gene 
expression analysis in 
embryonic SCs with 
the help of northern 
hybridization.  
(1)  RNA from embry‑
onic SCs transfected 
with a lp14g plasmid 
carrying the human 
GDNF gene fused 
with a GFP gene.
(2) RNA from embry‑
onic SCs transfected 
with a pEGFP-
N1plasmid carrying 
the GFP gene.
(3) RNA from non‑
transfected embry‑
onic SCs.
Fig. 5. Immunocyto‑
chemichal coloring of 
the es‑GFP line cells 
(A) and es‑GDNF (B) 
by the antibodies to 
human GDNF (x 100). 
russia) in a dilation of 1 : 500  and incubated for 2 h at room 
temperature and then processed in a peroxidase conjugate 
with streptavidin (Imtek, russia) in a dilution  of 1 : 400 
for 1 h at room temperature. the reaction was developed 
by the use of a 0.015% solution of 3-amino-9-ethylcarbasol 
(Sigma, united States) in 50 mM tris-citrate рН 7.0 buffer 
containing 0.06% Н2О2. coloring development was visually 
controlled with using an Olympus cKX41 (Olympus, Japan) 
microscope. the reaction ended with the cells being washed 
three times with distilled water.
STATISTICAL ANALySIS results were processed with the help of 
Sigma Plot (Jandel Scientific, united States) software. the 
validity of the group average differences were estimated 
with the help of dispersion analysis (one-way AnOVA). re-
sults were represented in the form of standard error (mean 
± SeM). Values of differences at p < 0.05 were considered 
valid. 
RESEARCH RESuLTS
During the initial stages of work, the presence of en expres-
sion of the receptors for GDnF - ret and GFrα1 on the 
мРНК level was determined in the embryonic Scs of the ini-
tial r1 line mouse with the help of rt (Pcr). the findings 
are presented in Figs. 2A and 2B.  It is seen from this infor-
mation that embryonic Scs are expressed by both GFrα1 
and ret, though with different efficiencies.
two lines were obtained as a result of transfection with 
corresponding recombinant plasmids and further selection 
of the embryonic Scs: es-GDnF (the line bearing the GDnF 
gene fused with the “green protein” gene) and es-GFP (the 
control line only, with the “green protein” gene).  the pres-
ence of the GFP gene insertion makes detecting the cell col-
onies easier after the transfection has been carried out; it 
also makes it easier to investigate the ways and patterns of 
the embryonic Scs differentiation, especially in in vivo tests. 
the green glow was observed in more than 80% (Fig. 3B) of 
transfected cells in the received cells' lineages. With the help 
of northern hybridization, coupled with the use of the la-
beled GDnF fragment, its expression in the es-GDnF line 
cells (Fig.4) was shown. Besides, as can also be seen from this 
picture, the expression of the endogenous GDnF gene hap-
A B114 | ActA nAturAe |  № 1 2009
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size their own GDnF in small amounts. Indirect confirma-
tion of this was, as has already been mentioned, obtained 
with the help of northern hybridization (Figs. 4 2 and 4 3). 
Brightly colored cell clusters are evidence of human GDFn 
synthesis in the es-GDnF line cells (Fig. 5B).
the influence of the human GDnF gene expression on 
the proliferative activity of the embryonic Scs was stud-
ied during the next stage. the proliferative activity of the 
control and experimental cell comparisons did not detect 
valid differences between them (this data has not been cit-
ed). these results allow us to suggest that the human GDnF 
gene product does not play an essential part in the cell-cycle 
regulation of these cells. 
the analysis of this genetic expression's influence on the 
initial stage of the differentiation of the transfected embry-
onic Scs–eBs formation was examined.  During research, 
the time of the eBs formation and their number was deter-
mined. the results of these experiments (eBs calculation was 
done on the 3rd and 4th days after the cell seeding) showed 
that the es-GDnF line cells form eBs almost concurrently 
with the control ones; however, the number of the eBs in 
the es-GDnF line cells was 40—45% lower than in the es-
GPF line (Fig.6). these findings point to the fact that there 
is a verifiable decrease in the eB number in the es-GDnF 
line cells when compared to the controls, which testifies to 
the inhibiting GDFn influence on the earlier stages of the 
embryonic Sc differentiation stage. 
consequently, as a result of the experiments, the embry-
onic mouse Scs that express the human GDnF gene fused 
with the GFP gene were obtained and partly character-
ized. the increased expression of the given gene leads to the 
slowing-down of the eB formation without influencing the 
morphology and proliferative activity of the transfected em-
bryonic Scs. In the future, the given cells' line may be used 
both to investigate the way the human GDnF gene influenc-
es further stages of embryonic Scs in vitro, especially in the 
neuronal direction, and for in vivo experiments with the pur-
Fig. 6. hGDNF gene expression influence on the formation of the embroid 
bodies transfected by embryonic SCs in vitro.
(1, 2) number of formed EBs on the 3rd day after cell seeding.
(3, 4) number of formed EBs on the 4th day after cell seeding.
White columns indicate the (es‑GFP) control. Grey columns are the (es‑
GDNF) test 
* p < 0,05, n = 30.
pose of correcting several brain pathologies connected with 
neurodegenerative illnesses such as Parkinson disease. 
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